| Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019 |
485 |
| Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) |
415 |
| Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range |
283 |
| Economic Costs of Diabetes in the US in 2017 |
279 |
| Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018 |
227 |
| Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019 |
196 |
| Glycemic Targets: Standards of Medical Care in Diabetes-2019 |
148 |
| Lifestyle Management: Standards of Medical Care in Diabetes-2019 |
113 |
| Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030 |
112 |
| Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report |
92 |
| Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018 |
84 |
| Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials |
84 |
| Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis |
83 |
| Glycemic Targets: Standards of Medical Care in Diabetes-2018 |
80 |
| Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial) |
79 |
| Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2019 |
78 |
| Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018 |
76 |
| Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study |
73 |
| Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes |
67 |
| Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2019 |
67 |
| Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum |
66 |
| Lifestyle Management: Standards of Medical Care in Diabetes-2018 |
66 |
| Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial |
55 |
| Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2018 |
55 |
| International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors |
50 |
| Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study |
50 |
| Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial |
50 |
| Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials |
50 |
| The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study) |
50 |
| Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism |
49 |
| Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars |
49 |
| Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2018 |
49 |
| Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association |
46 |
| Current Challenges and Opportunities in the Prevention and Management of Diabetic Foot Ulcers |
46 |
| Long-term Trends in Antidiabetes Drug Usage in the US: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes |
45 |
| Insulin Access and Affordability Working Group: Conclusions and Recommendations |
44 |
| PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes |
43 |
| Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial |
43 |
| Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study |
43 |
| More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial |
40 |
| Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis |
37 |
| Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial |
36 |
| The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older US Adults |
36 |
| Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial |
34 |
| Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019 |
34 |
| Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial |
32 |
| Night Shift Work, Genetic Risk, and Type 2 Diabetes in the UK Biobank |
32 |
| Resurgence of Diabetes-Related Nontraumatic Lower-Extremity Amputation in the Young and Middle-Aged Adult US Population |
32 |
| Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018 |
32 |
| Gestational Diabetes Mellitus and Diet: A Systematic Review and Meta-analysis of Randomized Controlled Trials Examining the Impact of Modified Dietary Interventions on Maternal Glucose Control and Neonatal Birth Weight |
31 |
| SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management |
31 |
| Hyperbaric Oxygen Therapy in the Treatment of Ischemic Lower- Extremity Ulcers in Patients With Diabetes: Results of the DAMO(2)CLES Multicenter Randomized Clinical Trial |
29 |
| An Automated Grading System for Detection of Vision-Threatening Referable Diabetic Retinopathy on the Basis of Color Fundus Photographs |
29 |
| HbA(1c) and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study |
29 |
| Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association |
28 |
| Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors |
27 |
| Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany |
27 |
| Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark |
27 |
| Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp |
26 |
| Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital |
26 |
| The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes |
26 |
| Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial |
26 |
| Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes |
25 |
| Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4 |
25 |
| Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial |
25 |
| Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2019 |
25 |
| Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial |
25 |
| Children and Adolescents: Standards of Medical Care in Diabetes-2019 |
25 |
| One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System |
24 |
| Global Diabetes Prevention Interventions: A Systematic Review and Network Meta-analysis of the Real-World Impact on Incidence, Weight, and Glucose |
24 |
| Hypogonadotropic Hypogonadism in Men With Diabesity |
24 |
| The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients |
24 |
| Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis |
24 |
| Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism |
24 |
| Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study |
23 |
| Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study |
23 |
| Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial |
23 |
| Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial |
23 |
| Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019 |
22 |
| First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes |
22 |
| Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study |
22 |
| Disparities in Environmental Exposures to Endocrine-Disrupting Chemicals and Diabetes Risk in Vulnerable Populations |
22 |
| Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes |
22 |
| Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System |
21 |
| Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study |
21 |
| Risk of Cardiovascular Disease and Death in Individuals With Prediabetes Defined by Different Criteria: The Whitehall II Study |
21 |
| Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial |
21 |
| Improved Open-Loop Glucose Control With Basal Insulin Reduction 90 Minutes Before Aerobic Exercise in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion |
21 |
| Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes |
20 |
| Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? |
20 |
| Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience |
20 |
| Effect of A1C and Glucose on Postoperative Mortality in Noncardiac and Cardiac Surgeries |
20 |
| Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype |
20 |
| Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998-2013: A Retrospective Cohort Study |
20 |
| Probiotics for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Women: Findings From the SPRING Double-Blind Randomized Controlled Trial |
20 |
| Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission |
19 |
| Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study |
19 |
| The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction |
19 |
| Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes |
19 |
| Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes |
19 |
| Maternal Gestational Diabetes Mellitus, Type 1 Diabetes, and Type 2 Diabetes During Pregnancy and Risk of ADHD in Offspring |
19 |
| Children and Adolescents: Standards of Medical Care in Diabetes-2018 |
19 |
| Health Care Utilization and Burden of Diabetic Ketoacidosis in the US Over the Past Decade: A Nationwide Analysis |
19 |
| Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2019 |
18 |
| Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in US Adult Patients With Type 1 Diabetes: A Real-World Study |
18 |
| C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase |
18 |
| Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study |
18 |
| Effects of Pemafibrate, a Novel Selective PPAR alpha Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial |
18 |
| Prediabetes Is Associated With Structural Brain Abnormalities: The Maastricht Study |
18 |
| Exploring Variation in Glycemic Control Across and Within Eight High-Income Countries: A Cross-sectional Analysis of 666 Children and Adolescents With Type 1 Diabetes |
18 |
| Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria |
17 |
| Temporal Trends and Contemporary Use of Insulin Pump Therapy and Glucose Monitoring Among Children, Adolescents, and Adults With Type 1 Diabetes Between 1995 and 2017 |
17 |
| Impact of Early Diabetic Ketoacidosis on the Developing Brain |
17 |
| Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes |
17 |
| Clinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study |
17 |
| Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study |
17 |
| The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes |
17 |
| Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score |
17 |
| Limb- and Person-Level Risk Factors for Lower-Limb Amputation in the Prospective Seattle Diabetic Foot Study |
17 |
| Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2018 |
17 |
| Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018 |
17 |
| Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia |
16 |
| A Population-Based Study of the Bidirectional Association Between Obstructive Sleep Apnea and Type 2 Diabetes in Three Prospective US Cohorts |
16 |
| Gaps in Guidelines for the Management of Diabetes in Low- and Middle-Income Versus High-Income Countries-A Systematic Review |
16 |
| Childhood BMI and Adult Type 2 Diabetes, Coronary Artery Diseases, Chronic Kidney Disease, and Cardiometabolic Traits: A Mendelian Randomization Analysis |
16 |
| Combined GLP- Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study |
16 |
| Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes |
16 |
| High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan |
16 |
| Enhanced Predictive Capability of a 1-Hour Oral Glucose Tolerance Test: A Prospective Population-Based Cohort Study |
16 |
| Pancreas Volume Declines During the First Year After Diagnosis of Type 1 Diabetes and Exhibits Altered Diffusion at Disease Onset |
16 |
| Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome |
16 |
| Diabetes Distress and Glycemic Control: The Buffering Effect of Autonomy Support From Important Family Members and Friends |
15 |
| Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis |
15 |
| Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes |
15 |
| Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study |
15 |
| Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease |
15 |
| General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort |
15 |
| Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes |
15 |
| Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial |
15 |
| PedsQL 3.2 Diabetes Module for Children, Adolescents, and Young Adults: Reliability and Validity in Type 1 Diabetes |
15 |
| Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019 |
15 |
| Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes |
15 |
| Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors |
15 |
| Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride |
15 |
| First Look at Control-IQ: A New-Generation Automated Insulin Delivery System |
14 |
| Maternal and Newborn Vitamin D-Binding Protein, Vitamin D Levels, Vitamin D Receptor Genotype, and Childhood Type 1 Diabetes |
14 |
| Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes |
14 |
| Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A(1c) on Risk of Diabetes and Complications in Chinese Adults |
14 |
| Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and-2 |
14 |
| The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial |
14 |
| Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes |
14 |
| Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2018 |
14 |
| Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance |
14 |
| Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 000 Patient-Years |
14 |
| From Hong Kong Diabetes Register to JADE Program to RAMP-DM for Data-Driven Actions |
14 |
| High-Coverage Targeted Lipidomics Reveals Novel Serum Lipid Predictors and Lipid Pathway Dysregulation Antecedent to Type 2 Diabetes Onset in Normoglycemic Chinese Adults |
13 |
| Food Insecurity, Food Deserts, and Glycemic Control in Patients With Diabetes: A Longitudinal Analysis |
13 |
| The Presence of Diabetes and Higher HbA(1c) Are Independently Associated With Adverse Outcomes After Surgery |
13 |
| Outcomes at 18 Months From a Community Health Worker and Peer Leader Diabetes Self-Management Program for Latino Adults |
13 |
| Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: II. Observations Using the Oral Glucose Tolerance Test |
13 |
| Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report |
13 |
| Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON |
13 |
| Diagnostic Accuracy of a Device for the Automated Detection of Diabetic Retinopathy in a Primary Care Setting |
13 |
| Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial |
13 |
| A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk |
13 |
| Low-Dose Anti-Thymocyte Globulin (ATG) Preserves -Cell Function and Improves HbA(1c) in New-Onset Type 1 Diabetes |
13 |
| Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2019 |
13 |
| The Use of Continuous Glucose Monitoring With Remote Monitoring Improves Psychosocial Measures in Parents of Children With Type 1 Diabetes: A Randomized Crossover Trial |
13 |
| Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes |
13 |
| Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and Meta-analysis of Randomized Controlled Trials |
13 |
| Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus |
13 |
| Trends and Disparities in Cardiovascular Mortality Among US Adults With and Without Self-Reported Diabetes, 1988-2015 |
13 |
| Elevated TyG Index Predicts Progression of Coronary Artery Calcification |
13 |
| Duration of Diabetes and Prediabetes During Adulthood and Subclinical Atherosclerosis and Cardiac Dysfunction in Middle Age: The CARDIA Study |
13 |
| The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome |
13 |
| Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data |
13 |
| Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2018 |
12 |
| Prevalence and Prognostic Impact of Diabetes in Takotsubo Syndrome: Insights From the International, Multicenter GEIST Registry |
12 |
| Disordered Eating Behaviors in Youth and Young Adults With Type 1 or Type 2 Diabetes Receiving Insulin Therapy: The SEARCH for Diabetes in Youth Study |
12 |
| Cross-sectional and Prospective Associations of Actigraphy-Assessed Sleep Regularity With Metabolic Abnormalities: The Multi-Ethnic Study of Atherosclerosis |
12 |
| Diabetes and Trajectories of Estimated Glomerular Filtration Rate: A Prospective Cohort Analysis of the Atherosclerosis Risk in Communities Study |
12 |
| The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study |
12 |
| Assessing Health-Related Quality of Life in Patients With Diabetic Foot Disease: Why Is It Important and How Can We Improve? The 2017 Roger E. Pecoraro Award Lecture |
12 |
| Racial/Ethnic Disparities in the Prevalence of Diabetes and Prediabetes by BMI: Patient Outcomes Research To Advance Learning (PORTAL) Multisite Cohort of Adults in the US |
12 |
| Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset |
12 |
| Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial |
12 |
| Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus |
12 |
| Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program |
12 |
| Risk of Hypoglycemia Following Hospital Discharge in Patients With Diabetes and Acute Kidney Injury |
12 |
| Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S |
12 |
| Effect of High-Deductible Insurance on High-Acuity Outcomes in Diabetes: A Natural Experiment for Translation in Diabetes (NEXT-D) Study |
12 |
| T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes |
12 |
| Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score |
12 |
| Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study |
12 |
| Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial |
11 |
| Gestational Diabetes Mellitus: Does One Size Fit All? A Challenge to Uniform Worldwide Diagnostic Thresholds |
11 |
| The Human Placenta in Diabetes and Obesity: Friend or Foe? The 2017 Norbert Freinkel Award Lecture |
11 |
| Declining Rates of Hospitalization for Selected Cardiovascular Disease Conditions Among Adults Aged >= 35 Years With Diagnosed Diabetes, US, 1998-2014 |
11 |
| Pathophysiological Characteristics Underlying Different Glucose Response Curves: A Latent Class Trajectory Analysis From the Prospective EGIR-RISC Study |
11 |
| Comparative Effects of Proximal and Distal Small Intestinal Glucose Exposure on Glycemia, Incretin Hormone Secretion, and the Incretin Effect in Health and Type 2 Diabetes |
11 |
